GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models-Reference-Cited by-同舟云学术

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models

Published:2007-02-27 Issue:3 Volume:321 Page:1032-1045
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Medhurst Andrew D.,Atkins Alan R.,Beresford Isabel J.,Brackenborough Kim,Briggs Michael A.,Calver Andrew R.,Cilia Jackie,Cluderay Jane E.,Crook Barry,Davis John B.,Davis Rebecca K.,Davis Robert P.,Dawson Lee A.,Foley Andrew G.,Gartlon Jane,Gonzalez M. Isabel,Heslop Teresa,Hirst Warren D.,Jennings Carol,Jones Declan N. C.,Lacroix Laurent P.,Martyn Abbe,Ociepka Sandrine,Ray Alison,Regan Ciaran M.,Roberts Jennifer C.,Schogger Joanne,Southam Eric,Stean Tania O.,Trail Brenda K.,Upton Neil,Wadsworth Graham,Wald Jeffrey A.,White Trevor,Witherington Jason,Woolley Marie L.,Worby Angela,Wilson David M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference43 articles.

1. Distribution and Modulation of Histamine H3 Receptors in Basal Ganglia and Frontal Cortex of Healthy Controls and Patients with Parkinson's Disease

2. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

3. Bamford MJ, Dean DK, Sehmi SS, Wilson DM, and Witherington J (2004) inventors

4. Glaxo Group Limited, assignees. Benzodiazepine derivatives for the treatment of neurological disorders. World patent WO 2004/056369 A1. 2004 Jul 8.

5. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist

Cited by 287 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity;Biomolecules;2024-06-26

2. Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder;Pharmaceuticals;2024-06-25

3. 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H₃ Receptors and Cholinesterases;ACS Chemical Neuroscience;2024-03-05

4. Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls;International Journal of Neuropsychopharmacology;2024-02-19

5. Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease;International Journal of Molecular Sciences;2024-01-08